Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study

This project will provide novel data using a large cohort of more than 3000 transplanted patients. Risk and protective factors for SARS-CoV-2 infection and COVID-19 disease severity will be identified. The proportion of patients who develop antibodies after infection will be revealed. In this way the presence of these antibodies can be evaluated as a test for prior infection. Our study additionally will demonstrate how long these antibodies remain present and whether they are protective against a new infection.

NCT Number	NCT04579471
Lead Sponsor	Universitaire Ziekenhuizen KU Leuven Collaborators: KU Leuven, Hasselt University, Ziekenhuis Oost-Limburg, Jessa Hospital
Conditions	Covid19, SARS-CoV Infection, Transplantation Infection
Enrollment	2,000 participants
Start Date	2020-07-01
Primary Completion	2021-12-31 (estimated)
Study Completion	2025-12-31 (estimated)
Updated on ClinicalTrials.gov	2024-07-03